Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Significance of endothelial progenitor cells in subjects with diabetes.

× No keyword cloud information.

52 in total

Review 1. The emerging relationship between regenerative medicine and physical therapeutics.

Authors: Fabrisia Ambrosio; Steven L Wolf; Anthony Delitto; G Kelley Fitzgerald; Stephen F Badylak; Michael L Boninger; Alan J Russell
Journal: Phys Ther Date: 2010-10-28

2. Effects of metformin plus gliclazide compared with metformin alone on circulating endothelial progenitor cell in type 2 diabetic patients.

Authors: Lu-lu Chen; Yun-fei Liao; Tian-shu Zeng; Fan Yu; Hui-qing Li; Yong Feng
Journal: Endocrine Date: 2010-10-23 Impact factor: 3.633

Review 3. A reappraisal of the role of circulating (progenitor) cells in the pathobiology of diabetic complications.

Authors: G P Fadini
Journal: Diabetologia Date: 2013-10-31 Impact factor: 10.122

Review 4. An underlying principle for the study of circulating progenitor cells in diabetes and its complications.

Authors: G P Fadini
Journal: Diabetologia Date: 2008-07 Impact factor: 10.122

Review 5. The promise of cell-based therapies for diabetic complications: challenges and solutions.

Authors: Yagna P R Jarajapu; Maria B Grant
Journal: Circ Res Date: 2010-03-19 Impact factor: 17.367

Review 6. A comparison of stem cells for therapeutic use.

Authors: Denis O Rodgerson; Alan G Harris
Journal: Stem Cell Rev Rep Date: 2011-11 Impact factor: 5.739

7. Glucose tolerance is negatively associated with circulating progenitor cell levels.

Authors: G P Fadini; L Pucci; R Vanacore; I Baesso; G Penno; A Balbarini; R Di Stefano; R Miccoli; S de Kreutzenberg; A Coracina; A Tiengo; C Agostini; S Del Prato; A Avogaro
Journal: Diabetologia Date: 2007-06-20 Impact factor: 10.122

8. Generalised reduction of putative endothelial progenitors and CXCR4-positive peripheral blood cells in type 2 diabetes.

Authors: C G Egan; R Lavery; F Caporali; C Fondelli; F Laghi-Pasini; F Dotta; V Sorrentino
Journal: Diabetologia Date: 2008-02-20 Impact factor: 10.122

9. The oral dipeptidyl peptidase-4 inhibitor sitagliptin increases circulating endothelial progenitor cells in patients with type 2 diabetes: possible role of stromal-derived factor-1alpha.

Authors: Gian Paolo Fadini; Elisa Boscaro; Mattia Albiero; Lisa Menegazzo; Vera Frison; Saula de Kreutzenberg; Carlo Agostini; Antonio Tiengo; Angelo Avogaro
Journal: Diabetes Care Date: 2010-03-31 Impact factor: 19.112

10. Time course and mechanisms of circulating progenitor cell reduction in the natural history of type 2 diabetes.

Authors: Gian Paolo Fadini; Elisa Boscaro; Saula de Kreutzenberg; Carlo Agostini; Florian Seeger; Stefanie Dimmeler; Andreas Zeiher; Antonio Tiengo; Angelo Avogaro
Journal: Diabetes Care Date: 2010-02-11 Impact factor: 19.112